|
TRPC4AP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.041280E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.407900E-02 |
| Normal-vs-Stage2 |
1.562620E-01 |
| Normal-vs-Stage3 |
2.923300E-03 |
| Normal-vs-Stage4 |
3.418400E-01 |
| Stage1-vs-Stage2 |
5.646000E-01 |
| Stage1-vs-Stage3 |
1.812160E-02 |
| Stage1-vs-Stage4 |
8.441400E-01 |
| Stage2-vs-Stage3 |
1.215230E-01 |
| Stage2-vs-Stage4 |
5.743000E-01 |
| Stage3-vs-Stage4 |
2.282400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.778700E-03 |
| Normal-vs-AfricanAmerican |
5.097600E-02 |
| Normal-vs-Asian |
1.945830E-01 |
| Caucasian-vs-AfricanAmerican |
7.913600E-01 |
| Caucasian-vs-Asian |
3.627600E-01 |
| AfricanAmerican-vs-Asian |
2.507400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.512200E-02 |
| Normal-vs-Female |
1.040050E-04 |
| Male-vs-Female |
7.180200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.740000E-02 |
| Normal-vs-Extreme_Weight |
5.217600E-01 |
| Normal-vs-Obese |
2.668000E-02 |
| Normal-vs-Extreme_Obese |
3.172600E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.064800E-01 |
| Normal_Weight-vs-Obese |
7.576000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.700600E-01 |
| Extreme_Weight-vs-Obese |
9.796300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.287200E-01 |
| Obese-vs-Extreme_Obese |
9.839000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.940170E-03 |
| Normal-vs-Age(41-60Yrs) |
1.362300E-04 |
| Normal-vs-Age(61-80Yrs) |
2.145000E-01 |
| Normal-vs-Age(81-100Yrs) |
6.925600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.417100E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.284400E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.645900E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.577600E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.998700E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.331700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.610200E-02 |
| Normal-VS-Type2 PRCC |
3.411600E-01 |
| Normal-VS-KIRP CIMP |
3.092400E-02 |
| Normal-VS-Unclassified PRCC |
6.152100E-04 |
| Type1 PRCC-VS-Type2 PRCC |
4.935800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.655100E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
9.898300E-03 |
| Type2 PRCC-VS-KIRP CIMP |
8.916500E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.517400E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
6.007400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.263400E-01 |
| Normal-vs-N1 |
1.940930E-03 |
| Normal-vs-N2 |
5.835000E-01 |
| N0-vs-N1 |
1.892400E-02 |
| N0-vs-N2 |
9.104000E-01 |
| N1-vs-N2 |
3.726000E-01 |
|
|
